Biochemical markers - Summary of recommendations and evidence
Troponins are the biomarkers of choice for diagnosing patients with suspected AMI.	I	A
When highly sensitive troponin assays are available, no other marker should be requested for routine AMI diagnosis.	I	B
Biochemical biomarkers of myocardial necrosis should be measured in all patients with suspected NSTE-ACS. When highly sensitive troponin assays are available, serum levels should be measured on admission and, ideally, reassessed in 1 h or up to 2 h. If unavailable, conventional troponin measurement should be performed at admission and repeated at least once, 3 to 6 hours later, if the initial results are normal or slightly elevated.	I	B
CK-MB mass levels can be used if troponin assays are unavailable.	IIb	B
Myoglobin can be used to detect myocardial necrosis in patients with suspected NSTE-ACS.	II